Flexural rigidity

CathSOLVER™ simplifies MicroCatheter Design Development

Retrieved on: 
Friday, March 1, 2024
Software, SAN, EI, Torque, Multimedia, ID, Stiffness, User, Ultimate tensile strength, OD, Flexural rigidity, Artificial intelligence

SAN ANTONIO, Feb. 29, 2024 /PRNewswire-PRWeb/ -- Roth Technologies, LLC announces the immediate release of the CathSOLVER™ function add-in for the CathCAD® Standard software for all licensed Users.

Key Points: 
  • CathCAD® modernized the microcatheter design process in 2012 by solving the forward problem catheter design problem numerically, that is, given the geometry and the physical characteristics of the design, the Software computed the functional characteristics of the design including longitudinal rigidity, flexural rigidity, torsional rigidity, kink radius, and the applicable failure modes.
  • CathSOLVER™ solves the inverse catheter design problem, that is, given a set of desired characteristics (ID, OD, number of layers, and desired physical attributes), the Software will compute and provide the "best" design that meets the catheter design requirements.
  • When the applicable design parameters are fully developed by the User, the CathSOLVER™ algorithm executes hundred of designs iterations resulting in the Software determining the best design given the User's defined constraints.
  • When the applicable design parameters are fully developed by the User, the CathSOLVER™ algorithm executes hundred of designs iterations resulting in the Software determining the best design given the User's defined constraints.

BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies

Retrieved on: 
Wednesday, December 30, 2020
Medical specialties, Aging-associated diseases, Coronary artery disease, Ischemia, Flexural rigidity, Clinical medicine, Medicine

This patent covers a steerable designintended to provide uniform bending rigidity in all orientations.This uniform bending rigidity is expected to significant enhance physician control in tortuous anatomy.

Key Points: 
  • This patent covers a steerable designintended to provide uniform bending rigidity in all orientations.This uniform bending rigidity is expected to significant enhance physician control in tortuous anatomy.
  • The advances also are expected to strengthen the Companys clinical stage biotherapeutic programs in heart failure and chronic myocardial ischemia.
  • BioCardia, Inc. , headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular and respiratory disease.
  • BioCardia expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.